CClinicalTrials.gg
CompletedNCT02903693DepColUpdated Sep 16, 2016

Cervical Cancer in French Guiana: Screening Between 2006-2011

An observational study in Cervical Cancer, sponsored by Centre Hospitalier de Cayenne. Completed at 1 site in France. Open to female participants. Per ClinicalTrials.gov, last updated 2016-09-16.

Sponsored by Centre Hospitalier de Cayenne · Observational

Study type
Observational
Time perspective
Cross-sectional
Enrollment
91,458
Sex
Female
01

Study summary

Given that cervical cancer is the second most frequent cancer among women in french guiana the aim of the study was to determine the screening rate among women living in French Guiana. Cervical smears are read in 2 laboratories which allowed us to compute screening rates per 100 women-years. overall the screening activity was 23.5-25.8 smears per 100 women-years. between 2006 and 2011 54% of women were screened. These baseline figures will allow to evaluate present efforts to increase the screening rate for this frequent cancer in French Guiana.

02

Conditions studied

  • Cervical Cancer
03

In context

Uterine Cervical Neoplasms

1,883 studies on the registry are indexed under Uterine Cervical Neoplasms; 567 are open to participants now.

This study's enrollment of 91,458 is above the median of 220 across 420 observational studies indexed under Uterine Cervical Neoplasms.

Browse Uterine Cervical Neoplasms studies →

Lead sponsor

Centre Hospitalier de Cayenne is the lead sponsor of 47 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

all women screened for cervical cancer using pap smear

Inclusion criteria

  • women screened

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Time perspective
Cross-sectional
Enrollment
91,458 participants (actual)
Patient registry
No

Interventions

  • Othercross sectional
06

What researchers measure

Primary outcomes

  1. cervical cancer screening

    Cytological examination screens for neoplasic lesion according to the Bethsda 2001, results are assessed on a yearly basis to obtain annual screening rates relative to the female population.

    Time frame: 1 year (screening that year)

07

Study locations

1 site
  • Centre Hospitalier de Cayenne
    Cayenne, French Guiana 97306, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02903693
Lead sponsor
Centre Hospitalier de Cayenne
Responsible party
Sponsor
First posted
Sep 16, 2016
Start date
Sep 2012
Primary completion
Sep 2012
Completion
Jun 2013
Last update
Sep 16, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion